TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
ITGR

Integer Holdings Corp

Healthcare · Medical Devices

126.30$ +0.2% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Ratios

Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.

Tick rows to compare them in a chart (up to 4)

Ratios ITGR
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
Valuation
32.5 37.2 41.6 39.0 41.0 40.1 52.1 53.2 42.3 26.8 21.4 24.9
1.7 2.1 2.5 2.5 2.8 2.8 2.3 2.5 2.0 1.5 1.6 1.7
1.8 2.2 2.7 2.6 2.9 3.0 2.5 2.6 2.1 1.6 1.8 1.9
2.3 2.7 3.2 3.2 3.4 3.4 3.0 3.1 2.6 2.1 2.3 2.4
13.5 15.4 17.8 16.9 17.7 17.3 17.9 19.0 16.4 13.2 12.9 14.1
42.9 55.9 56.0 62.7 62.9 48.2 35.9 36.5 30.3 26.2 30.4 28.5
2.3% 1.8% 1.8% 1.6% 1.6% 2.1% 2.8% 2.7% 3.3% 3.8% 3.3% 3.5%
Margins
24.9% 25.7% 25.9% 27.0% 27.2% 26.8% 26.2% 25.0% 24.0% 23.2% 23.3% 23.7%
10.7% 10.5% 10.6% 11.3% 11.6% 12.1% 12.7% 12.3% 11.8% 11.3% 10.4% 9.5%
5.3% 5.7% 6.1% 6.4% 6.8% 7.0% 4.4% 4.6% 4.8% 5.6% 7.7% 7.0%
4.0% 3.8% 4.5% 4.0% 4.4% 5.8% 6.4% 6.7% 6.6% 5.7% 5.4% 6.1%
Returns
5.6% 6.0% 6.4% 6.8% 7.0% 7.4% 4.8% 4.8% 5.0% 5.9% 8.4% 7.5%
2.9% 3.1% 3.1% 3.4% 3.6% 3.9% 2.3% 2.5% 2.6% 3.0% 4.2% 3.8%
Balance Sheet & Debt
919 947 1,107 1,093 1,053 959 1,212 1,188 1,144 1,190 1,252 1,225
3.5 3.4 3.8 3.6 3.3 2.9 4.2 4.0 3.9 4.0 3.8 3.9
51.5% 51.6% 48.9% 49.7% 51.2% 52.6% 48.7% 50.5% 51.4% 51.2% 49.7% 50.2%
0.7 0.6 0.8 0.7 0.7 0.6 0.8 0.7 0.7 0.7 0.7 0.7
Per Share
2.41 2.67 2.80 2.97 3.17 3.31 2.27 2.31 2.44 2.92 4.12 3.76
45.85 46.48 45.98 46.07 46.70 47.36 51.45 50.12 51.25 52.54 53.72 53.92
43.33 44.69 43.58 43.74 45.30 44.68 47.37 47.70 49.03 49.70 49.28 50.34
1.83 1.77 2.08 1.85 2.07 2.75 3.29 3.37 3.41 2.99 2.90 3.28

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?